These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17227727)

  • 21. Iodine-131 therapy of hyperthyroidism in pediatric patients.
    Clark JD; Gelfand MJ; Elgazzar AH
    J Nucl Med; 1995 Mar; 36(3):442-5. PubMed ID: 7884506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism].
    Mihailović J; Malesević M; Stefanović L; Krkljus D
    Med Pregl; 1995; 48(11-12):412-5. PubMed ID: 8643057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
    Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
    J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Graves-Basedow's disease with 131I. Assessment of a "modulated fixed activity" protocol].
    Abós D; Ruiz P; Prats E; Razola P; García F; Tardín L; Banzo J
    Rev Esp Med Nucl; 2007; 26(1):3-10. PubMed ID: 17286943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake.
    Kristoffersen US; Hesse B; Rasmussen AK; Kjaer A
    Clin Physiol Funct Imaging; 2006 May; 26(3):167-70. PubMed ID: 16640512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with chronic hepatitis type C and interferon-alpha-induced hyperthyroidism in two-years clinical follow-up.
    Czarnywojtek A; Zgorzalewicz-Stachowiak M; Wasko R; Czepczynski R; Szczepanek-Parulska E; Waligorska-Stachura J; Kurdybacha P; Bereszynska I; Florek E; Stangierski A; Zdanowska J; Nikisch E; Sowinski J; Ruchala M
    Neuro Endocrinol Lett; 2013; 34(2):154-61. PubMed ID: 23645313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism.
    Robertson JS; Gorman CA
    J Nucl Med; 1976 Sep; 17(9):826-35. PubMed ID: 956897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
    Baczyk M; Junik R; Ziemnicka K; Sowiński J
    Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
    Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of radioiodine therapy with fixed doses of 10 and 15 mCi in patients with Graves' disease].
    Canadas V; Vilar L; Moura E; Brito A; Castellar E
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1069-76. PubMed ID: 18157381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre.
    Danaci M; Feek CM; Notghi A; Merrick MV; Padfield PL; Edwards CR
    N Z Med J; 1988 Nov; 101(858):784-6. PubMed ID: 3194075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease.
    Willemsen UF; Knesewitsch P; Kreisig T; Pickardt CR; Kirsch CM
    Eur J Nucl Med; 1993 Nov; 20(11):1051-5. PubMed ID: 8287872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors.
    Gupta SK; McGrath S; Rogers K; Attia J; Lewis G; Viswanathan S; Saul M; Allen L
    Intern Med J; 2010 Dec; 40(12):854-7. PubMed ID: 21199224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial to evaluate the effectiveness of 2 regimens of fixed iodine (¹³¹I) doses for Graves disease treatment.
    Santos RB; Romaldini JH; Ward LS
    Clin Nucl Med; 2012 Mar; 37(3):241-4. PubMed ID: 22310249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
    Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
    Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
    Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
    J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule.
    Zakavi SR; Mousavi Z; Davachi B
    Nucl Med Commun; 2009 Feb; 30(2):169-75. PubMed ID: 19194214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.